Literature DB >> 17289760

Evaluation of the Etest method for fosfomycin susceptibility of ESBL-producing Klebsiella pneumoniae.

Lorena López-Cerero, Marina de Cueto, Miguel Angel Díaz-Guerrero, Concepción Morillo, Alvaro Pascual.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17289760     DOI： 10.1093/jac/dkl545

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

1.  Uropathogen distribution and antimicrobial susceptibility in uncomplicated cystitis in Belgium, a high antibiotics prescribing country: 20-year surveillance.

Authors:  S Heytens; J Boelens; G Claeys; A DeSutter; T Christiaens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-17       Impact factor: 3.267

2.  In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin.

Authors:  Andrea Endimiani; Gopi Patel; Kristine M Hujer; Mahesh Swaminathan; Federico Perez; Louis B Rice; Michael R Jacobs; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2009-11-09       Impact factor: 5.191

3.  Multicenter Evaluation of the Novel ETEST Fosfomycin for Antimicrobial Susceptibility Testing of Enterobacterales, Enterococcus faecalis, and Staphylococcus Species.

Authors:  A Goer; L S Blanchard; A Van Belkum; K J Loftus; T P Armstrong; S G Gatermann; D Shortridge; B J Olson; J K Meece; T R Fritsche; M Pompilio; D Halimi; C Franceschi
Journal:  J Clin Microbiol       Date:  2022-06-23       Impact factor: 11.677

4.  Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin.

Authors:  M E Falagas; M D Kanellopoulou; D E Karageorgopoulos; G Dimopoulos; P I Rafailidis; N D Skarmoutsou; E A Papafrangas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-23       Impact factor: 3.267

5.  In vitro activity of fosfomycin against a collection of clinical Pseudomonas aeruginosa isolates from 16 Spanish hospitals: establishing the validity of standard broth microdilution as susceptibility testing method.

Authors:  María Díez-Aguilar; María-Isabel Morosini; Rosa del Campo; María García-Castillo; Javier Zamora; Rafael Cantón
Journal:  Antimicrob Agents Chemother       Date:  2013-08-12       Impact factor: 5.191

Review 6.  Present and Future Perspectives on Therapeutic Options for Carbapenemase-Producing Enterobacterales Infections.

Authors:  Corneliu Ovidiu Vrancianu; Elena Georgiana Dobre; Irina Gheorghe; Ilda Barbu; Roxana Elena Cristian; Mariana Carmen Chifiriuc
Journal:  Microorganisms       Date:  2021-03-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.